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  Background:  Spinal anesthesia in the sitting position with low-dose local anesthetics usually provides satisfactory anesthesia 
for diabetic foot surgery because most operations do not require tourniquet application.  This study was designed to investigate 
the influence of different sitting periods after subarachnoid injection of low dose bupivacaine on the spread of analgesia.
  Methods:  In this randomized, controlled clinical trial, 60 patients undergoing diabetic foot surgery under spinal anesthesia 
without a tourniquet were randomized to three groups.  Patients remained sitting for 2 (Group D2, n = 20), 5 (Group D5, n = 20), 
or 10 (Group D10, n = 20) min after the completion of subarachnoid administration of 3.75 mg of 0.25% hyperbaric bupivacaine 
solution. They were then placed in the supine position.  Analgesia levels were assessed bilaterally using pinpricks.  Blood pressure 
and heart rate were also recorded. 
  Results:  The maximal sensory block level [median (range)] was higher in Group D2 [L3 (L2-L3)] compared with Group D10 
[L4 (L3-L4)] (P = 0.002).  The highest sensory block levels were T12, T11, and L2 in Group D2, 5 and 10, respectively.  There 
were no hemodynamic differences among the three groups and none of the patients showed hemodynamic instability except for 
one patient in Group D10. 
  Conclusions:  Although spinal anesthesia using a minimal dose of 0.25% hyperbaric bupivacaine provides adequate anesthesia 
for diabetic foot surgery without profound hypotension, regardless of the time spent in the sitting position, maintaining the position 
for 10 min required to confine the sensory blockade on the lower level.  (Korean J Anesthesiol 2009; 56: 273～9)
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INTRODUCTION 
  A diabetic foot ulcer is a serious complication of long-term 
diabetes. Surgery for the diabetic foot is a relatively minor op-
eration with negligible blood loss, but providing anesthesia for 
these patients is a frequent challenge because of serious co-
morbidities. Cardiovascular autonomic neuropathy is associated 
with increased morbidity and mortality [1], and hemodynamic 
instability is common in patients with autonomic dysfunction 
during anesthesia induction and maintenance [2,3]. It is im-
portant to maintain anesthesia as stable as possible including 
adequate analgesia.
  Although there is no clear evidence that one type of anes-
thetic is superior for patients with diabetes, the stress response 
to surgery may be reduced with combinations of local or re-
gional anesthesia and the administration of opioids [4]. 
Regional anesthesia is a reasonable choice for lower extremity 
operations in diabetic patients [5]. When spinal anesthesia is 
planned, high sensory block levels are not required, especially 
when a tourniquet is not used. Limiting the block to lower 
dermatomal levels and avoiding the occurrence of hypotension 
is important because fluid loading and vasopressor admin-
istration may not be ideal methods to prevent or treat hypo-
tension since end-stage renal disease and coronary artery occlu-
sive disease are common in these patients. A peak level of 
sensory block of only L4 or even L5 provides sufficient anes-
thesia, and spinal anesthesia with a low dose of local anes-
thetics with the patient in the sitting position is one method to 
minimize analgesic level and the occurrence of hypotension. It 
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has been suggested that when compared with the general pop-
ulation, patients with preexisting sensorimotor neuropathy or di-
abetic polyneuropathy may be at increased risk of further neu-
rologic sequelae after neuraxial anesthesia or analgesia [6,7]. 
Diabetic nerve fibers may be more susceptible to the toxic ef-
fects of local anesthetics [7]. Minimizing the concentration of 
local anesthetics can be safe for patients undergoing diabetic 
foot surgery. 
  This study was designed to investigate the influence of dif-
ferent sitting periods after subarachnoid injection of a small 
dose (3.75 mg) of hyperbaric 0.25% bupivacaine on the spread 
of analgesia.
MATERIALS AND METHODS
  After obtaining approval from the Hospital Ethics Committee 
and written informed consent from the subjects, sixty adult pa-
tients undergoing diabetic foot surgery without tourniquet were 
enrolled in this study. All patients were admitted prior to the 
surgical procedure for daily dressing and control of infection 
of diabetic foot. Patients were checked for sensory dysfunction 
in the dermatomes of the lower extremities to exclude pre-ex-
isting sensory loss from diabetic neuropathy. Patients were ex-
cluded from the study if they had coagulopathy, infection at 
the site of injection, or refusal to spinal anesthesia as well as 
pre-existing sensory loss. Subjects were randomly assigned to 
one of three study groups that differed with respect to the du-
ration that patients remained in the sitting position after in-
jection of an anesthetic agent. Group assignment was random-
ized using computer-generated randomization. 
  Premedication was not given to patients. When patients ar-
rived at the operating theatre, routine monitoring, including 
electrocardiogram, pulse-oximetry and non-invasive automated 
blood pressure were established. Heart rate (HR) and mean ar-
terial pressure (MAP) were recorded in the supine position as 
a baseline. Patients were slowly placed into a sitting position 
to prevent orthostatic hypotension. When patients were seated 
comfortably, HR and MAP were recorded every 5 min until 
the end of the operation. Before spinal anesthesia, no fluid 
loading was performed and normal saline was infused intra-
venously for maintenance. Dural puncture was performed in the 
sitting position with a standard midline approach using a 
22-gauge Quincke spinal needle at the L4-5 interspace. When 
a free flow of clear cerebrospinal fluid was confirmed, 1.5 ml 
of 0.25% bupivacaine (3.75 mg) was injected over 15 seconds 
with the spinal needle bevel toward the caudad direction. The 
hyperbaric 0.25% bupivacaine solution was made by mixing 
0.5% bupivacaine in 8% dextrose (MarcaineⓇ Spinal heavy, 
AstraZeneca, Södertälje, Sweden) with the same volume of 
0.9% saline. Patients remained seated for 2 min (Group D2), 5 
min (Group D5), or 10 min (Group D10) after subarachnoid 
injection of the anesthetic agent and then were returned to the 
supine position.
  Sensory block level was assessed bilaterally at the mid-
clavicular line by a pinprick test using a 24-gauge hypodermic 
needle. Assessments were made every 5 min during the first 
30 min after the injection and every 10 min thereafter until 
there was a 2-segment regression of sensory level. The max-
imal sensory block level (MSBL), the time at which MSBL 
was attained, increased sensory block levels after supine posi-
tioning, and the time to the 2-segment regression of sensory 
level were recorded. During the first 10 min, all assessments 
were made by the anesthesiologist who had performed the 
lumbar puncture. Thereafter, assessments were made by another 
anesthesiologist who was blinded to the patients’ group assign-
ment.
  No additional sedatives were given during the operation un-
less requested by the patient. When the patient complained of 
pain or discomfort, remifentanil was continuously infused intra-
venously at a rate of 0.1 to 0.2μgㆍkg−1ㆍmin−1. The blind-
ed anesthesiologist was allowed to convert to general anes-
thesia if an inadequate amount of anesthesia was continuously 
detected in spite of the infusion of remifentanil. Hypotension 
(defined as a systolic blood pressure of ＜ 90 mmHg or a de-
crease of mean arterial pressure by more than 25% of the 
pre-anesthetic baseline value) and bradycardia (defined as heart 
rate ＜ 50 beats/min) were treated by an intravenous bolus of 
ephedrine, phenylephrine, or atropine sulfate as deemed 
appropriate. Follow up was performed 1 day postoperatively by 
a blinded investigator who inquired about headaches (positional 
headache was considered to be a postdural puncture headache), 
backaches, urinary retention, and transient neurological symp-
toms (TNS), which are defined as pain radiating to the but-
tocks or legs and sensory disturbances in areas not related to 
the surgery.
  For the purpose of statistical analyses, each dermatomal lev-
el was scored in sequence starting at S5 = 1, such that S1 = 
5, L1 = 10, T8 = 15, and T3 = 20. Sample size was calcu-
lated based on the pilot study, since there was no previous 
study about the influence of different sitting periods after sub-
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Table 1. Characteristics of Patients and Duration of Surgery
Group D2 (n = 20) Group D5 (n = 20) Group D10 (n = 20)
Age (yr) 63.2 ± 8.0   61.8 ± 10.6  64.5 ± 8.8
Height (cm) 167.0 ± 7.5 164.3 ± 9.1 163.6 ± 9.0
Weight (kg)  66.7 ± 10.6  65.3 ± 9.9  60.9 ± 8.8
Sex (M：F) 17：3  15：5  15：5
ASA physical status (II：III)   9：11    6：14    5：15
Duration of surgery (min)  49.2 ± 20.1 45.9 ± 16.1   40.0 ± 14.6
Coexisting diseases 
  Hypertension 14 (70.0%) 16 (80.0%) 16 (80.0%)
  Coronary artery occlusive disease  7 (35.0%)  7 (35.0%)  9 (45.0%)
  End stage renal disease  7 (35.0%)  8 (40.0%) 10 (50.0%)
  Peripheral artery occlusive disease  2 (10.0%) 1 (5.0%)  2 (10.0%)
Name of operation 
  Debridement 10 (50.0%)  9 (45.0%)  7 (35.0%)
  Toe amputation  5 (25.0%)  8 (40.0%) 10 (50.0%)
  Ray amputation  4 (20.0%)  3 (15.0%) 1 (5.0%)
  Resection arthroplasty 1 (5.0%) 0 (0.0%)  2 (10.0%)
Values are mean ± SD or numbers. Patients in groups D2, D5 and D10 remained sitting for 2, 5 or 10 min after completion of the sub-
arachnoid injection.
Table 2. Sensory Block Characteristics
Group D2 (n = 20) Group D5 (n = 20) Group D10 (n = 20)
MSBL (dermatome) L3 (L2-L3 [T12-L4])b) L3.5 (L2-L3 [T11-L5]) L4 (L3-L4 [L2-L5])
Increase after supine positioning (dermatomes) 1 (0-2 [0-4])a) 0 (0-1 [0-4]) 0 (0-1 [0-2])
T-MSBL (min) 9.8 ± 5.7 10.5 ± 5.4  9.3 ± 5.2
TSRT (min) 95.0 ± 22.3 103.2 ± 32.6 114.5 ± 32.6
Values are median (interquartile ratio [range]), mean ± SD, or numbers. Groups D2, D5 and D10 = patients who remained sitting for 2, 5 
or 10 min after completion of the subarachnoid injection. MSBL: maximal sensory block level, T-MSBL: time to maximal sensory block 
level, TSRT: 2-segment regression time. a)Data in Group D2 are increased sensory block level after 5 min (analgesia levels were not as-
sessed at 2 min), b)Significantly different compared to Group D10 (P = 0.002).
arachnoid injection of low dose 3.75 mg of 0.25% bupivacaine 
on the spread of analgesia. Based on the results of our pilot 
study, more than 14 patients in each group were required in 
order to detect a difference of one dermatome analgesia levels 
to pinprick with a variability of 0.9 between with α error of 
0.05 and β error of 0.2. We decided to evaluate 20 patients 
in each group to compensate for possible protocol violations 
during the study period. 
  Statistical analyses were performed using software packages 
(SigmaStat 3.1 for Windows, Systat Software, Inc., CA., USA). 
Data are expressed as mean (SD), median (interquartile ratio 
[range]), or number of patients, as appropriate. MSBL, time to 
MSBL, and increased level of sensory block after supine posi-
tioning were analyzed by Kruskal-Wallis test followed by 
Tukey test. Changes in MAP and HR were analyzed by re-
peated measures of analysis of variance (ANOVA) corrected 
by the Bonferroni method. P value less than 0.05 was consid-
ered to be statistically significant.
RESULTS
  Sixty patients were enrolled from whom data were obtained 
between March 2006 and December 2007. Characteristics of 
the patients are summarized in Table 1. There were no differ-
ences among the groups. Hypertension, coronary artery occlu-
sive disease, and end-stage renal disease were found in 76.7%, 
38.3%, and 41.7% of all patients, respectively.
  The characteristics of sensory block are presented in Table 2. 
The individual times to MSBL revealed that sensory block lev-
el was fixed within 5 min in 28 out of 60 patients and the 
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Fig. 3. Changes in Heart rate (HR) during the 60 min after sub-
arachnoid injection. Values are mean ± SE. Groups D2, D5 and 
D10 = patients who remained sitting for 2, 5 or 10 min after 
completion of the subarachnoid injection. There were no significant 
differences among groups. a)P ＜ 0.05 compared with supine posi-
tion value in each group.
Fig. 2. Changes in mean arterial pressure (MAP) during the 60 
min after subarachnoid injection. Values are mean ± SE. Groups 
D2, D5 and D10 = patients who remained sitting for 2, 5 or 10 
min after completion of the subarachnoid injection. There were no 
significant differences among groups. a)P ＜ 0.05 compared with 
supine position value in each group. 
Fig. 1. Segmental spread of sensory analgesia after subarachnoid 
injection of 3.75 mg of 0.25% bupivacaine for diabetic foot 
surgery. Medians are corrected for tied observations. Groups D2, 
D5 and D10 = patients who remained sitting for 2, 5 or 10 min 
after completion of the subarachnoid injection. a)Significantly differ-
ent compared to Group D2 and D10 (P ＜ 0.008). 
longest time for fixation was 20 min in each group. The high-
est sensory block levels were T12, T11, and L2 in Group D2, 
5, and 10, respectively. MSBL of Group D2 was 1 dermatome 
higher than that of Group D10 (P = 0.002) (Table 2) (Fig. 1). 
MSBL of Group D10 showed the limited distribution of the 
local anesthetics (Table 2) (Fig. 1). There were no differences 
in the time to MSBL or increased levels of sensory block af-
ter supine positioning among the groups or two segment re-
gression time. 
  Analgesia was adequate during the whole period of surgery 
except for one patient in Group D2. Although the initial sen-
sory block was adequate, this patient required additional in-
fusion of intravenous remifentanil due to prolonged operation 
time (85 min after the induction of anesthesia).
  Changes in mean arterial pressure and heart rate were com-
parable among the groups (Fig. 2, 3). Only one patient in 
Group D10 received a single dose of 6 mg ephedrine. The 
blood pressure of that patient was 99/62 mmHg in the supine 
position, 90/64 mmHg in the sitting position, and 82/56 mmHg 
at 5 min after subarachnoid injection. Neither atropine nor phe-
nylephrine was used to treatment of bradycardia or hypotension 
in this study. Postoperative follow up revealed no headache, 
backache, urinary retention, or TNS.
DISCUSSION
  In this study, spinal anesthesia using 3.75 mg of hyperbaric 
0.25% bupivacaine in the sitting position ensured adequate an-
esthesia and maintained stable hemodynamics regardless of the 
duration of sitting. Although there was only one segment dif-
ference in MSBL between Group D2 and D10 statistically (P 
= 0.002), we found that the 10 min sitting period was re-
quired to confine the sensory blockade on the lower level. The 
highest MSBL was confined to L2 in Group D10, whereas the 
highest MSBL in Group D2 and D5 were T12 and T11, re-
spectively, even with small dose of bupivacaine. 
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Fig. 5. Individual maximal sensory block level of analgesia. 
Horizontal lines represent median levels. Medians are corrected for 
tied observations. Groups D2, D5 and D10 = patients who re-
mained sitting for 2, 5 or 10 min after completion of the sub-
arachnoid injection. a)Significantly different compared to Group D2 
and D10 (P = 0.002).
Fig. 4. Individual analgesia levels 5 min after the injection. 
Horizontal lines represent median levels. Medians are corrected for 
tied observations. Groups D2, D5 and D10 = patients who re-
mained sitting for 2, 5 or 10 min after completion of the sub-
arachnoid injection.
  There are three reasons to use 0.25% bupivacaine solution 
instead of 0.5%. First, when using the undiluted 0.5% bupiva-
caine solution in the sitting position, there is a high risk of 
localized anesthesia within the S-dermatome region. Secondly, 
it is highly probable that patients with DM foot disease also 
have nerve fiber neuropathies. It has been previously reported 
that DM patients are at a high risk of developing toxicity due 
to local anesthetics when used in high concentrations [6,7], 
and concentrations as low as 0.25% can induce sufficient sen-
sory and motor block in these patients. Finally, because 0.25% 
bupivacaine is weakly hyperbaric and thus settles at a slow 
rate at the injection site, we can anticipate effective analgesia 
at the desired dermatomes (below L3) than with high concen-
tration local anesthetics such as 0.5% bupivacaine.
  Among many factors that affect the intrathecal spread of lo-
cal anesthetics, the major factors are the baricity of the in-
jected solution and the posture of the patient [8]. Although it 
is generally believed that injection of hyperbaric local anes-
thetic solution in the sitting position would limit MSBL to 
lower levels, earlier studies on the time that the patient is kept 
in the sitting position after the subarachnoid injection of high 
doses (15−20 mg) of hyperbaric bupivacaine have demon-
strated that the time in the sitting position has little or no in-
fluence on the maximum cephalad spread of sensory analgesia 
[9-12]. The results were mainly determined by the final posi-
tion of the patients. When a larger volume (4 ml) of 0.5% 
bupivacaine was injected, even a sitting period of 60 min was 
not enough for the fixation of analgesic levels [12]. We used 
a small-dose (3.75 mg) of 0.25% hyperbaric bupivacaine unlike 
previous investigations [9-12]. 
  We did not measure sensory block level at 2 min when pa-
tients were moved into the supine position in Group D2, but 
there is a possibility that there was 1 segment upward pro-
gression between 2−5 min in this group compared to others 
because sensory block level at 5 min in Group D2 was 1 seg-
ment higher than that of Group D5 or D10 (Fig. 4). After 5 
min, increased sensory block level in Group D2 was similar to 
increased sensory level after supine positioning in Groups D5 
and D10. This would mean that when even a small dose of 
local anesthetic is injected into the subarachnoid space with 
the patient in the sitting position, a 2-min period of sitting is 
not sufficient enough to limit analgesic level. Although there 
was no statistical difference between Group D5 and D10 in re-
gard to MSBL, a 10-min sitting period after subarachnoid in-
jection is preferable for achieving a more consistent analgesic 
level because MSBL was demonstrated to have a lower in-
ter-individual variability in Group D10 (Fig. 5). In addition, 
MSBL was fixed during the period when the patient was sit-
ting in 15 patients in Group D10 (75.0%) compared to 8 pa-
tients in Group D5 (40.0%). 
  The presence of MSBL of L2, L1, or even T11 in this 
study suggests considerable inter-individual variances and the 
existence of many factors that determine sensory block levels 
we did not assess. Onset time to MSBL is determined by 2 
factors; the time needed for the local anesthetic to reach the 
highest spinal cord segment in a sufficient amount to produce 
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sensory block and the latency between the presence of local 
anesthetics at a given spinal cord segment and the time that 
signs of sensory block in the corresponding dermatome become 
apparent [13]. Onset time to MSBL in this study was also 
variable as with the level of MSBL, and it should be noted 
that in 5 patients, MSBL increased until 20 min after sub-
arachnoid injection. Whether this latency in onset time of 
MSBL is from the delayed movement of local anesthetics in 
the subarachnoid space or from the delayed response of the 
spinal cord segment is not clear from this study. The two-seg-
ment regression time (TSRT) from the MSBL showed the ten-
dency of prolongation with the duration of sitting period al-
though it did not statistically significant (P = 0.182) (Table 2).
  A 0.25% bupivacaine solution was made with 0.5% bupiva-
caine with the same volumes of 8% dextrose and 0.9% normal 
saline. The specific gravity of 0.25% bupivacaine in 4% dex-
trose at 37oC was 1.010, and it was hyperbaric compared to 
cerebrospinal fluid density in adults at 37oC (1.00054) [14]. 
Diluting 0.5% intrathecal bupivacaine in 8% dextrose solution 
with the same volume of saline was reported to have a faster 
recovery time [15], but this is a controversial issue because it 
is generally accepted that dosage rather than volume or con-
centration of the solution is the main factor that determines 
the duration of the block [17]. This was not a primary inves-
tigation point of this study. We used 3.75 mg of 0.25% hy-
perbaric bupivacaine and decreasing the bupivacaine dose could 
be considered but it might result in inadequate analgesia for 
the surgery because MSBL of 2 patients were already as low 
as L5 with 3.75 mg. Although all patients in this study 
showed stable hemodynamics during the period of sitting posi-
tion except one patient, ten minutes sitting for diabetic patients 
after subarachnoid injection can cause fainting. Careful mon-
itoring is mandatory for these patients during the sitting 
period.
  There are some limitations to this study. First, the measure-
ment of analgesia level at 2 min in Group D2 was not 
performed. This made it impossible to investigate actual in-
creased sensory block level after subjects in this group 
changed to the supine position. Second, we used a 22-gauge 
Quincke spinal needle because it is still the most commonly 
used in our department. Using the different types and gauges 
of spinal needle could result in different distribution of local 
anesthetics [16,17]. Among the different types of spinal nee-
dles, the Quincke needle can always produce an undeviated 
stream of anesthetics and do not form tracks at any flow rate 
[18]. 
  In conclusion, this study demonstrated that spinal anesthesia 
using a minimal dose of 0.25% hyperbaric bupivacaine with 
the patient in a sitting position provided adequate anesthesia 
for diabetic foot surgery without profound hypotension regard-
less of the time spent in the sitting position (2, 5, or 10 min) 
after subarachnoid injection. However, even with this small 
dose, keeping the patient in the sitting position for 2 or 5 min 
after subarachnoid injection was not adequate to confine the 
sensory blockade on the lower dermatome. 
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